ANV/3TC/TDF group:switch to ANV/3TC/TDF

Efficacy and metabolic parameters changing of switching to Ainuovirine, 3TC, and TDF in treatment experienced adults living with HIV due to dyslipidaemia or weight gain: week 48 results

Efficacy, safety and adherence of switching to Ainuovirine, 3TC, and TDF in treatment experienced adults living with HIV-1 due to CNS symptoms: week 48 results

Efficacy and effects on metabolic markers of switching to ANV/3TC/TDF single-tablet regimen versus switching to BIC/FTC/TAF regimen in suppressed treatment-experienced HIV-1 infected patients: Week 48 Results of multi-center, randomized Clinical trial